Drug Screening Market Research:
The global Drug Screening Market Size is expected to reach $9,447 million in 2023 from $5,214 million in 2016 registering a CAGR of 8.7%, during the forecast period, 2017 to 2023. Drug screening test analyses biological samples, such as blood, hair, & urine; to diagnose the presence of drug abuse or its metabolites in patient’s body. Drug screening tests are used to determine if person is or was under the influences of drug at a certain point of time. Drug screening devices have improved owing to introduction of new technology; offering the users precise and accurate results. Rise in alcohol consumption among youth as well as elderly population, overuse of prescribed drugs, increase in use of narcotics and illicit drugs is a major driver for the market.
Market Segmentation
The global drug screening market is segmented based on equipment and services, sample type, end user, and geography. Based on equipment and services, the drug screening market is divided into immunoassay analyzers, chromatography instruments, breath analyzers, breath analyzers, rapid testing devices, and urine testing devices. The breath analyzers are further classified into fuel cell breath analyzers, semiconductor breath analyzers, and other devices. The RTD (rapid testing devices) is bifurcated into urine testing devices and oral fluid/saliva testing devices. The urine testing devices are further classified into urine testing cups, dip cards and cassettes Based on consumables assay kits, sample collection cups, calibrators & controls, and other consumables. Laboratory services hold major market share in this segment. The sample type segment is divided into urine sample, breath sample, oral fluid sample, hair sample, and other sample (blood & sweat). Urines sample are widely used and draw a large amount of share in this segment. Based on end user, the industry is divided into workplace & school, drug testing laboratories, criminal justice & law enforcement agencies, hospitals, drug treatment centers, pain management centers, and personal users.
The impact of the driving factors is expected to overcome the effect of restraints. Increase in consumption of alcohol and illicit drugs, establishment of stringent laws in various countries, and increase in governmental funding to control drug trafficking provide opportunity for the drug screening devices. Immunoassay analyzers occupied the largest share in the drug screening equipment market in 2016.
Competitive Landscape
Key players operating in this drug screening market include Alere, Inc., Drägerwerk AG & Co. KGAA, Abbott Laboratories, Hoffmann-La Roche AG, Biorad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated and, Express Diagnostics International Inc.
Key Benefits
- The study provides an in-depth analysis of the global drug screening market size with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
- Comprehensive analysis of factors that drive and restrict the drug screening market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the drug screening market.
Drug Screening Market Key Segments:
By Product & Service
Equipment
- Immunoassay Analyzers
- Chromatography Instruments
- Breath Analyzers
- Fuel Cell Breathalyzers
- Semiconductor Breathalyzers
- Other Devices
- Rapid Testing Devices
- Urine Testing Devices
- Urine Testing Cups
- Dip Cards
- Cassettes
- Oral Fluid Testing Devices
- Urine Testing Devices
- Consumables
- Assay Kits
- Sample Collection Cups
- Calibrators and Controls
- Others
- Laboratory Services
By Sample Type
Urine Sample
- Breath Sample
- Oral Fluid Sample
- Hair Sample
- Others (Blood and Sweat Samples)
By End User
- Workplace and Schools
- Drug Testing Laboratories
- Criminal Justice System & Law Enforcement Agencies
- Hospitals
- Drug Treatment Centers
- Pain Management Centers
- Personal Users
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
Drug Screening Market Report Highlights
| Aspects | Details |
 By PRODUCT & SERVICE |
|
 By SAMPLE TYPE |
|
 By END USER |
|
 By GEOGRAPHY |
|
 Key Market Players | F. HOFFMANN-LA ROCHE AG (ROCHE DIAGNOSTICS), QUEST DIAGNOSTICS INCORPORATED, BIO-RAD LABORATORIES, INC., THERMO FISHER SCIENTIFIC INC., DRAGERWERK AG & CO. KGAA, ALERE INC., ABBOTT LABORATORIES, EXPRESS DIAGNOSTICS INTERNATIONAL INC., SIEMENS AKTIENGESELLSCHAFT, DANAHER CORPORATION |
Analyst Review
Drug abuse in work force can result in reduced productivity, absenteeism, injuries and accidents, poor decision making. In schools and colleges drug abuse can alter brain function and affect development of brain in students. Due to this reason, many employers and educational institutes have mandated the drug screening tests to be conducted before the admission of the candidates. More and more employers are turning towards a drug free workplace and thus boosting the growth of drug screening market. Many employers have initiated programs to help the workforce with the drug abuse problems, such as employee assistance program (EAP). These kind of programs provide complete employee assistance such as long term and short term counselling, marital and family problems, financial distress and any other personal problem that can affect employee’s work.
Drug screening has positively rewarded individuals and societies with the power of regulation and a drug free healthy environment. Schools and workplaces have made drugs tests mandatory due to familiarity of adverse effects of drugs and alcohol consumption. The government initiatives for research and development of drugs screening devices and to tackle the illegal drug trafficking are major drivers of the drug screening market.
Developed countries such as U.S. have established stringent laws to control the drug abuse problem, moreover increasing disposable income in developing countries have raised market potential for drug screening devices as untapped markets. However, countries with supplementary laws to protect privacy on an individual can hinder the growth of this market. Drug testing in such countries can be considered as invasion of individual’s privacy. Moreover, drugs test such as urine test which is widely used is not always accurate and can be manipulated. In order to overcome these limitations companies are coming up with new technologies such as (RTD) rapid testing devices and exploring other sample types such as hair sample, saliva sample to achieve precise results and results over long term drug abuse.
Currently hair sample is a fastest growing segment due to its prolonged detection period of drug abuse and precision level of result, hair sample segment is anticipated to grow at a significant rate during the forecast period. Workplace and schools at present are the largest end users of the drug screening devices. Increase in awareness regarding drug abuse has led to increase in personal users and this segment is expected to grow at fastest rate during the forecast period. Followed by law enforcement agencies because of firm government policies regarding drug abuse. Drug screening market is well established in North America owing to its application and awareness in the region. Developing countries are also working towards establishing strict laws and regulations regarding drug abuse due to its harmful effects on the individuals and society.
Loading Table Of Content...
